Kenvue He solved the proxy fight with the right activist, adding three new directors to his board.
Jeff Smith from the page will join the board Johnson and Johnson Spinoff with Sarah Hofstetter, president of Profitero, the e-commerce analytical performance platform and Eric Mann, former head of the pharmaceutical company Bayer Consumer Health Department.
“Building the Sarah brand and knowledge about digital marketing, global experience in the consumer health industry Eric and the perspective of investor Jeff and extensive service of corporate management boards will additionally strengthen the complementary management board, added to the value of skills,” said Larry Merlo, chairman of the board of Kenvue, in a w a statement Wednesday.
CNBC announced in October that the starboard had gathered a significant participation in the company and he expressed disappointment in the field of management and stock prices.
Kenvue is a producer of iconic brands known to both investors and a wider audience, such as Aveeno, Band-Aid, Listerine, Neutrogena, Tynenol and J&J, personal powder and shampoo.
J&J has completed the separation from Kenvue in August 2023 and since then he sold the remaining part of the giant of consumer goods. This meant the largest shock in the almost 140-year history of J&D.